Teva Pharmaceutical Industries Limited is believed to be in preliminary discussions to buy Handok Pharmaceuticals Co., Ltd., according to reports in JoongAng Dail. Young-Jin Kim, Chief Executive Officer and Chairman of Handok, holds 46.8% of Hando and IMM Private Equity owns 30% of Handok.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.94 USD | +0.03% | +1.46% | +62.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.88% | 19.17B | |
+42.69% | 739B | |
+32.34% | 598B | |
-6.08% | 353B | |
+17.22% | 318B | |
+3.34% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+5.79% | 164B |
- Stock Market
- Equities
- TEVA Stock
- News Teva Pharmaceutical Industries Limited
- Teva Reportedly In Talks To Acquire Handok Pharmaceuticals